US Patent Office Launches AI Initiative to Revolutionize Patent Filings

The United States Patent and Trademark Office (USPTO) has launched its Artificial Intelligence Search Automated Pilot (ASAP) program, a significant step forward in patent filing strategies. This initiative provides applicants with automated search results notices before substantive examination, potentially transforming how companies approach patent applications. By enabling earlier visibility into the prior art landscape, ASAP…

Read More

Tesla vs. Charge Fusion: The Critical Role of Precision in Patent Claims for Autonomous Technologies

The recent legal confrontation between Tesla and Charge Fusion has brought to light a nuanced aspect of patent drafting that can have significant implications for technology companies. At the heart of this case lies the interpretation of patent claims related to software that computes a charging schedule and autonomously causes a charging event. This distinction,…

Read More

Federal Circuit Reinvigorates VLSI’s Patent Dispute Against Intel, Overrules Prior Ruling

The Federal Circuit has rejuvenated a patent infringement lawsuit filed by VLSI Technology against Intel Corporation, overturning a prior decision by a California federal judge that had restricted the litigation’s scope. The case highlights ongoing complexities in patent agreements between tech giants, with the Federal Circuit identifying that the lower court had misinterpreted the contractual…

Read More

USPTO Denies Nike’s Trademark Application for Bronny James Logo, Highlighting Intellectual Property Challenges

The United States Patent and Trademark Office (USPTO) recently rejected Nike’s application to trademark the logo associated with Bronny James, the son of NBA star LeBron James and a player for the Los Angeles Lakers. This decision highlights ongoing challenges in trademark law, particularly as companies seek to protect intellectual property connected to high-profile individuals…

Read More

U.S. Federal Circuit Courts Upholds Invalidating Vehicle Engine Software Patent, Reinforces On-sale Bar Principle

The U.S. Court of Appeals for the Federal Circuit recently upheld a lower court decision invalidating a patent related to vehicle engine software, reaffirming the application of the on-sale bar principle in patent law. Powerteq LLC successfully argued that the software invention had been sold prior to the patent filing, rendering the patent invalid. This…

Read More

Third Circuit Upholds Denial of Johnson & Johnson Effort to Block Biosimilar Market Entry

The Third Circuit recently affirmed a lower court’s decision denying a Johnson & Johnson subsidiary’s attempt to block Samsung Bioepis from facilitating a generic drug launch by a Cigna unit. This legal battle centers around a biosimilar version of an anti-inflammatory treatment, highlighting the complexities and strategic maneuvering that characterize patent disputes in the biopharmaceutical…

Read More

Brightpick Seeks Court Ruling Against Ocado Over Warehouse Robotics Patent Dispute

Warehouse robotics company Brightpick has initiated legal proceedings in the Eastern District of Virginia, seeking a declaratory judgment that its “Gridpicker” system does not infringe upon seven U.S. patents held by Ocado Innovation Ltd. and Ocado Solutions Ltd., subsidiaries of the UK-based Ocado Group. The complaint, filed on April 12, 2026, follows a series of…

Read More

IP Edge Rebrands Amid Rising Scrutiny of Patent Assertion Practices

IP Edge, a significant player in the patent monetization arena, has recently undergone rebranding efforts amid heightened scrutiny. The firm’s decision comes in the wake of investigations probing its business practices, spotlighting the industry’s growing scrutiny over patent assertion entities frequently dubbed “patent trolls.” In particular, Bloomberg Law reports that IP Edge’s rebranding is seen…

Read More

Judge Dismisses Mylan’s Antitrust Claims Against Teva Over Copaxone in Legal Setback

A federal judge in New Jersey has rejected efforts by Mylan to revive antitrust claims against Teva Pharmaceuticals regarding its multiple sclerosis drug, Copaxone. This decision came after endorsing a special master’s recommendations to dismiss certain claims from Mylan and other entities like Walgreens. The allegations involved accusations that Teva engaged in regulatory deception and…

Read More

Hikma Pharmaceuticals Seeks Supreme Court Intervention in Landmark Patent Case Over “Skinny Label” Strategy

In a significant legal maneuver, Hikma Pharmaceuticals USA Inc. has appealed to the U.S. Supreme Court, asserting that the Court’s recent decision in a copyright case involving an internet company supports its position in an ongoing patent dispute. The case at hand involves Hikma’s generic version of a heart medication originally developed by Amarin Pharma…

Read More

Genius Sports Seeks Court Order for Panda Interactive’s Settlement Reveal in Patent Litigation Battle

In a legal maneuver illustrating the competitive dynamics of the sports technology industry, Genius Sports Ltd. has requested that a Texas federal court compel Panda Interactive to disclose a settlement agreement reached in a previous patent lawsuit. This request is rooted in Genius Sports’ ongoing effort to obtain discovery materials that may be crucial in…

Read More

FN Herstal Sues Glock in Key Patent Battle Over Pistol Design Features

In a recent development in the firearms industry, FN Herstal, a prominent Belgian gun manufacturer, has initiated legal proceedings against Glock Inc., asserting that the Austrian company’s latest offering, the Glock Gen6 pistols, infringes on their patent. The lawsuit, filed in Georgia federal court, specifically targets Glock’s design feature that allows users to attach optic…

Read More

Heartflow Inc. Sues Ex-Consultant for Alleged Patent Infringement in AI Cardiac Imaging

AI-powered cardiac imaging company Heartflow Inc. has filed a legal complaint against a former consultant, alleging patent infringement and misappropriation of trade secrets. The lawsuit targets a competitor founded by the ex-consultant, who Heartflow claims improperly accessed and used proprietary technology during his tenure with the company. According to a report by Law360, this action…

Read More

GAO Calls for Reform of Bayh-Dole Act Reporting to Enhance Innovation Compliance

In recent developments, the U.S. Government Accountability Office (GAO) has highlighted issues with the Bayh-Dole Act reporting requirements, which are pivotal for universities and businesses holding patent rights on inventions developed with federal funding. The reporting complexities are becoming a bottleneck for compliance, leading to potential inefficiencies in the patent process (Law360). Under the provisions…

Read More

Federal Circuit Upholds Patent Board Ruling Against AlmondNet, Affirming Meta’s Legal Win in Ad Tech Dispute

In a recent legal development, the Federal Circuit has upheld the Patent Trial and Appeal Board’s decision involving Meta Platforms Inc. The ruling confirmed the invalidation of all claims challenged by Meta against a patent held by AlmondNet Inc., a company specializing in advertising technology. The court’s decision, delivered on Monday, signals a continued trend…

Read More

Federal Circuit Upholds Patent Validity in Cisco-Ramot Case, Reinforcing University Innovation Rights

The U.S. Court of Appeals for the Federal Circuit recently held firm in its decision to reject Cisco Systems Inc.’s effort to reinstate challenges to two patents held by Ramot at Tel Aviv University. These patents, which concern data conversion technology, were under scrutiny as Cisco questioned their validity. However, the Federal Circuit supported the…

Read More

U.S. ITC to Investigate Potential Patent Infringement in Lidocaine Patch Imports

On Monday, the U.S. International Trade Commission (ITC) announced that it will investigate whether imported over-the-counter lidocaine patches sold by five companies infringe upon a U.S. patent. This investigation could potentially lead to exclusion orders preventing these products from entering the U.S. market, a significant move within the realm of international trade and patent law….

Read More

Federal Circuit Affirms PTAB Ruling, Reinvigorating Patent Claim Standards in Tech Sector

The Federal Circuit recently upheld a ruling by the Patent Trial and Appeal Board (PTAB), affirming the invalidity of claims within a contested video-decoding patent. This decision came after the patent holder argued against the restrictions on presenting written description support during the proceedings. This verdict impacts the domain of intellectual property, reinforcing the standards…

Read More

USPTO Launches Pilot Program to Streamline Patent Examination Amid Backlog Concerns

The U.S. Patent and Trademark Office (USPTO) has announced a pilot program that hopes to streamline the patent examination process, addressing long-standing concerns over examination backlogs. The program, revealed on April 10, 2026, introduces a new requirement for certain applicants in the national stage to actively request the examination of their patent applications, a move…

Read More

U.S. Federal Circuit Upholds Microsoft’s Victory in Mobile Architecture Patent Case

In a significant decision for intellectual property and technology law, the U.S. Court of Appeals for the Federal Circuit upheld the Patent Trial and Appeal Board’s (PTAB) ruling, affirming that Microsoft Corporation successfully demonstrated the invalidity of claims from Lemko Corp.’s distributed mobile architecture patent. This comes as an important development in the ongoing interplay…

Read More

Federal Circuit’s Approach to Trade Secret Law Signals Significant Shift in Intellectual Property Strategy

The Federal Circuit’s evolving view of trade secrets represents a significant shift in the landscape of intellectual property law. Traditionally governed by common law and the Uniform Trade Secrets Act (UTSA), as adopted by individual states, trade secret law saw a change with the introduction of the federal Defend Trade Secrets Act (DTSA) in 2016….

Read More

Federal Circuit Affirms PTAB’s Rejection of Sentient Sensors Patent Claims, Emphasizes Stringent Innovation Standards

The United States Court of Appeals for the Federal Circuit recently decided to uphold the Patent Trial and Appeal Board’s (PTAB) conclusion that claims associated with a Sentient Sensors monitoring patent lacked innovation and were therefore deemed obvious. The case revolved around patent claims concerning technology employed in military instrument monitoring systems. The Federal Circuit’s…

Read More